Mechanism of o-aminophenol metabolism in human erythrocytes  by Tomoda, Akio et al.
Volume 196, number 1 FEBS 3337 February 1986 
Mechanism of o-aminophenol metabolism in human 
erythrocytes 
Akio Tomoda, Jundo Yamaguchi, Hisanori Kojima, Hidemitsu Amemiya* and 
Yoshimasa Yoneyama 
Department of Biochemistry, Kanazawa University School of Medicine, Kanazawa, Ishikawa 920 and *Fuji Chemical 
Industries, 530 Choke& Takaoka, Toyama, Japan 
Received 26 November 1985 
o-Aminophenol was found to be rapidly metabolized to a brown compound in the presence of purified hu- 
man oxy- and methemoglobin, coupled with the oxidation and reduction of these hemoglobins by o-amino- 
phenol. The final product of o-aminophenol was identified as 2-aminophenoxazine-3-one, by using spectro- 
photometry and HPLC. The metabolism of o-aminophenol was also observed in human erythrocytes. The 
production rates of 2-aminophenoxazine-3-one in the cells were very fast, but these were strongly decreased 
by bubbling carbon monoxide into the cell suspension when intracellular hemoglobin was in the ferrous 
state. The production of 2-aminophenoxazine-3-one from o-aminophenol in the cells was completely sup- 
pressed by cyanide and azide when intracellular hemoglobin was in the ferric state. These results suggest 
that oxy- and methemoglobin are involved in metabolism of o-aminophenol to 2-aminophenoxazine-3-one 
in human erythrocytes. 
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1. INTRODUCTION 
It is well known that o-aminophenol causes toxic 
methemoglobinemia, oxidizing intracellular he- 
moglobin of human erythrocytes [l]. This com- 
pound has been shown to oxidize oxyhemoglobin 
very rapidly to methemoglobin in vitro [2,3]. 
However, it has not been determined whether o- 
aminophenol is metabolized by human eryth- 
rocytes, coupled with the oxidation of intracellular 
hemoglobin. We found that o-aminophenol is 
rapidly metabolized to 2-aminophenoxazine-3-one, 
a brown compound produced by the oxidative 
dimerization of o-aminophenol, in human 
erythrocytes. This work is a first report on the 
metabolism of o-aminophenol by human 
erythrocytes. 
2. MATERIALS AND METHODS 
Human hemoglobin was purified as in [4]. 
Methemoglobin was obtained by the oxidation of 
purified hemoglobin with ferricyanide [5]. A solu- 
tion of 3.0 ml of oxy- or methemoglobin (120,~M 
in heme) in 20 mM potassium phosphate buffer 
@H 7.0) was mixed with o-aminophenol solution 
(Wako, Tokyo, final concentrations: 1 mM), 
which was previously neutralized with 0.1 M 
NaOH. The reaction was performed at 37°C for 
60 min. Then 0.5 ml of the reaction mixture was 
passed through a column (0.5 x 10 cm) of 
Sephadex G-25 (fine grade) previously equilibrated 
with 50 mM potassium phosphate buffer, pH 7.0. 
The brown solutions which come after hemoglobin 
and include o-aminophenol and its metabolic 
product were identified using spectrophotometry, 
and HPLC. Authentic 2-aminophenoxazine-3-one 
was obtained according to Osman and Bassiouni 
[6] and used for comparison. 
Human erythrocytes were collected from ACD 
(acid/citrate/dextrose) blood samples, which were 
obtained from a local blood bank (3 days out- 
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dated). After washing the cells, the erythrocytes 
were suspended in a Krebs Ringer solution to give 
a hematocrit of 18%. o-Aminophenol, which was 
dissolved in 0.9% NaCl solution and then 
neutralized with 0.1 M NaOH solution to make a 
20 mM solution, was gently added to the suspen- 
sion. The final concentrations of o-aminophenol in 
the suspension were 1 mM. After adjustment of 
the cell suspension pH to 7.0 at 37”C, the suspen- 
sion was incubated with o-aminophenol at 37°C 
for 3 h. The experiments were performed in the 
presence or absence of potassium cyanide (final 
concentration 1 mM), sodium azide (final concen- 
tration 1 mM) and carbon monoxide. Carbon 
monoxide was bubbled into the cell suspensions. 
The erythrocytes with methemoglobin were ob- 
tained by oxidation of intracellular hemoglobin 
with nitrite [7]. The samples were taken out at in- 
tervals for analysis and were lyzed by repeated 
freeze-thawing. Then the hemolysates were passed 
through a column of Sephadex G-25 (fine grade) 
equilibrated with 50 mM potassium phosphate 
buffer, pH 7.0. The brown fractions which come 
after hemoglobin and include o-aminophenol and 
its metabolic product, were analyzed by spec- 
trophotometry and HPLC. 
3. RESULTS 
3.1. ~eta~~~s~ of o-a~~no~heno~ by oxy- 
We studied the reactions of o-aminophenol with 
oxy- and methemoglobin. Fig. 1 shows the changes 
in absorption spectra between 350 and 550 nm of 
the samples prepared by passing the reaction mix- 
tures of o-~inophenol and oxyhemoglobin 
through a column of Sephadex G-25 (fine grade). 
The eluates free of oxyhemoglobin showed 
characteristic spectra with increasing absorbance 
near 435 nm with time. The absorption spectra of 
the sample at 120 min were very similar to those of 
authentic 2-~inophenox~ne-3~ne. Nagasawa 
et al. [8] showed that o-aminophenol is converted 
to 2-aminophenoxazine-3-one by cytochrome c, a 
hemoprotein with protoporphyrin-like hemoglobin 
and cytochrome oxidase. They showed charac- 
teristic absorption spectra of 2+uninophenoxa- 
zine3-one in 1: 1 chloroform/eth~ol solution, 
being consistent with our results in the inset to 
fig.1 (absorption spectra shown by broken lines). 
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Fig. I. Changes in absorption spectra during the reaction 
of o-aminophenol with oxyhemoglobin. o-Aminophenol 
(final concentration 1 mM) was incubated with 
oxyhemoglobin (120,~M in heme) at pH 7.0, 37T for 
60 min. The samples were removed at intervals for 
analysis and were passed through a column of Sephadex 
G-25 (fine grade) equilibrated with 50 mM phosphate 
buffer, pH 7.0. The eluates were subjected to optical 
measurements. (Inset) Absorption spectra of the sample 
at 60 min in a variety of solutions: (-) phosphate 
buffer, (---) 1: 1 chloroform/ethanol solution, 
f-----) dilute HCl solution, (---) dilute NaOH 
solution. 
Gerber and Lechevalier [9] obtained the values 
X,,, in HzO, 240 and 435 nm; A,, in diluted HCI 
solution, 237 and 468 nm; h,, in diluted NaOH 
solution, 335 nm. Our results shown in fig. 1 (inset} 
are in good agreement with these values. There- 
fore, these results suggest hat o-aminophenol is 
converted to 2-aminophenoxazine-3-one during in- 
cubation of oxyhemoglobin and o-aminophenol. 
Oxyhemoglobin was rapidly oxidized to 
methemoglobin within 30 min, indicating that ox- 
yhemoglobin is involved in the metabolism of o- 
aminophenol (not shown). To identify the product 
of o-aminophenol with oxyhemoglobin, we studied 
the HPLC patterns of o-aminophenol, p-benzo- 
quinone, authentic 2-~nophenox~ne-3-one and 
the product of o-aminophenol with oxyhemo- 
globin (fig.2). As a result, the patterns of the 
product of o-aminophenol with oxyhemoglobin 
were in good agreement with those of authentic 
2-aminophenoxazine3-one in position, showing 
that o-aminophenol was converted to 2-amino- 
phenox~ne-3-one by oxyhemoglobin. 
We also investigated whether o-aminophenol is 
metabolized by methemoglobin. Consequently, 
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Fig.2. HPLC patterns of o-~i~ophenol, p-benzo- 
quinone, authentic 2-aminophenoxazine-3-one and the 
product of o-aminophenol with oxyhemoglobin. The 
samples were applied to an HPLC apparatus (Toyo 
Soda, Japan) with a column (type ODS 120 T). (A) 
Authentic o-aminophenol, (B) authentic p-benzo- 
quinone, (C) products of the reactions of o-aminophenol 
with p-benzoquinone, (D) products of the reactions of o- 
aminophenol with purified hemoglobin for 30 min. 
Z-~inophenox~ine-3-one was produced when o- 
aminophenol was incubated with methemoglobin, 
because characteristic spectra with peaks at 240 
and 435 nm for 2-aminophenoxazine-3-one were 
observed in the samples including o-aminophenol 
and methemoglobin. Fig.3 shows the comparison 
of the 2-aminophenoxazine-3-one formation as 
detected by the changes in absorbance at 435 nm 
when o-aminophenol was incubated with oxy- and 
methemoglobin. The rates of 2-aminophenoxa- 
zine-3-one formation with oxyhemoglobin were 
faster than those with methemoglobin. We also 
observed that methemoglobin was reduced by o- 
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Fig.3. Changes in absorbance at 435 nm during 
incubation of o-~inophenol with oxyhemo~obin or 
methemoglobin. Changes in absorbance at 435 nm 
during incubation of o-aminophenol with oxyhemo- 
globin (0) or methemoglobin (0) were plotted vs time. 
aminophenol, indicating that the reduction of 
methemoglobin is involved in metabolism of o- 
aminophenol (not shown). 
Since we observed that o-aminophenol is 
metabolized by oxy- or methemoglobin, we in- 
vestigated whether o-aminophenol is converted to 
2-aminophenoxazine-3-one in human erythrocytes, 
where there is abundant hemoglobin. The absorp- 
tion spectra characteristic of 2-aminophenoxa- 
zine3-one increased with time between 350 and 
550 nm (typical peak at 435 nm), when 
erythrocytes were incubated with o-aminophe- 
no1 for 150 min at 37”C, indicating that 2- 
aminophenox~ine-3-one is progressively pro- 
duced in human erythrocytes coupled with the 
oxidation of intracellular hemoglobin (we ob- 
served that intracellular oxyhemoglobin was ox- 
idized to methemoglobin by o-aminophenol within 
60 min; not shown here). Thus, the rates of 
2-aminophenox~ne-3-one formation were esti- 
mated by the changes in absorbance at 435 nm. 
The time course of 2-aminophenoxazine-3-one 
production during 150 min incubation of eryth- 
rocytes with o-aminophenol under different condi- 
tions is shown in fig.4. When intracellular hemo- 
globin was in the oxy form in erythrocytes, the 
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rates of 2-aminophenoxazine-3-one formation 
were very fast (about 9OO~M/ml cells per h; this 
value was estimated taking account of the em = 
1.1 for 2-~inophenox~ne-3-one [9]), being com- 
parable to the rates of glucose consumption in 
human erythrocytes at physiological pH. How- 
ever, when intracellular hemoglobin was converted 
to the carboxy form, the reaction was greatly sup- 
pressed. This fact supports the views that ox- 
yhemoglobin is responsible for the formation of 
2-aminophenoxazine-3-one from o-aminophenol, 
and carboxyhemoglobin is not. Sodium azide, an 
inhibitor of catalase, did not influence 2-amino- 
phenoxazine3-one. On the other hand, when in- 
tracellular hemoglobin was converted to methe- 
moglobin and incubated with o-aminophenol, 
2-aminophenoxazine-3-one was produced, though 
the production rates were somewhat slower com- 
pared with the case of the control experiment with 
oxyhemoglobin, being consistent with the results in 
fig.3. However, the production of 2-aminophe- 
noxazine-3-one was completely suppressed when 
sodium azide or potassium cyanide was previously 
added to the erythrocyte suspension containing 
methemoglobin. These results mean that methe- 
moglobin is also involved in the metabolism of o- 
~inophenol to 2-~inophenox~ne-3~ne in 
human erythrocytes, but that the cyanide or azide 
methemoglobin complex is inert to the metabolism 
of the compound. 
15" 30 60 150 Scheme 1. Me~bolism of o-aminophenol to t-amino- 
Time (mini phenoxazine-3-one by human hemoglobin. 
Fig.4. Metabolism of o-aminophenol in human 
erythrocytes under different conditions. Human 
erythrocytes were incubated with o-aminophenol atpH 
7.0 and 37*C for 150 min under various conditions. 
unclear, but it is possible that a quantity of 
2-aminophenoxazine-3-one might be produced in a 
patient of toxic methemoglobinemia with o- 
aminophenol. 
4. DISCUSSION 
Our results show that o-aminophenol is 
metabolized to 2-aminophenox~ine-3-one by 
purified human oxy- and methemoglobin (figs 
l-3). The same results were observed in human 
erythrocytes (fig.4). Since human erythrocytes 
contain a large quantity of hemoglobin inside, it is 
possible that this hemoprotein plays an important 
role in the metabolism of o-aminophenol to 
2-aminophenoxazine-3-one in the cells. This view 
is supported by the results that the metabolism of 
o-aminophenol was much suppressed in the 
presence of CO gas when intracellular hemoglobin 
was in the ferrous state, and completely suppressed 
when intracellular hemoglobin was in the ferric 
state. We previously reported that 3-hydroxy- 
anthranilic acid, which is an important tryptophan 
metabolite and has an analogous structure to o- 
aminophenol, is oxidatively dimerized to cin- 
nab~ini~ acid by human hemoglobin and 
erythrocytes [lo]. Our results are also very 
analogous to the reaction of o-aminophenol with 
cytochrome c and cytochrome-c oxidase [S], and 
with isophenoxazine synthase from Pycnoporus 
coccineus [111. From these reports, the metabolism 
of o-~inophenol to 2-~inophenox~ine-3-one 
by human hemoglobin may be visualized as 
follows. 
The physioIogical significance of o-aminophenol 
metabolism by human erythrocytes remains 
0: --en: 
o-Ammophenol o-q”lno,mcna 
2-Aminophenoxoztne-3-one 
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